Legal Representation
Attorney
Katharine Tremblay
USPTO Deadlines
Application History
48 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 14, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 12, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 25, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 25, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 24, 2021 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Aug 24, 2021 | PGRR | O | PETITION GRANTED - RESPONSE RECEIVED | Loading... |
| Jul 22, 2021 | ERTP | I | TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED | Loading... |
| Jun 29, 2021 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Jun 18, 2021 | TPDR | I | TEAS PETITION TO DIRECTOR RECEIVED | Loading... |
| May 28, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 27, 2021 | SNEA | W | SU-EXAMINER'S AMENDMENT WRITTEN | Loading... |
| May 27, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 27, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 19, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 12, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 12, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 12, 2020 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Oct 22, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 21, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 21, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Oct 15, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 15, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 15, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 18, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 17, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 17, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 30, 2020 | PILM | I | PETITION INQUIRY LETTER ISSUED | Loading... |
| Jun 23, 2020 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Jun 22, 2020 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Jun 22, 2020 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jun 22, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 22, 2020 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Jun 22, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 22, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 19, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 19, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 24, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 24, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 4, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 16, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 15, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 15, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 14, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 14, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 14, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 13, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 11, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 28, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Allergy medications; Homeopathic pharmaceuticals for use in the treatment of dry eye; Medical preparations for the treatment of dry eye; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations for the treatment and prevention of dry eye; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of dry eye; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Plant and herb extracts sold as components of medicated cosmetics; Drug delivery agents in the form of dry eye that facilitate the delivery of pharmaceutical preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparation for skin care; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for treating allergies; Pharmaceutical products for ophthalmological use
First Use Anywhere:
Jun 28, 2016
First Use in Commerce:
Jun 28, 2016
Additional Information
Pseudo Mark
RE TEAR
Classification
International Classes
005